Implementing interventions targeted at discordant couples: a feasibility analysis for 14 African countries

Size: px
Start display at page:

Download "Implementing interventions targeted at discordant couples: a feasibility analysis for 14 African countries"

Transcription

1 Implementing interventions targeted at discordant couples: a feasibility analysis for 14 African countries Brian J. Coburn and Sally Blower Center for Biomedical Modeling Semel Institute for Neuroscience & Human Behavior David Geffen School of Medicine at UCLA 7 th International Workshop on HIV Transmission: Principles of intervention July 2012, Washington, DC USA Funded by NIH/NIAID

2 Epidemic Control of SDC Interventions Are SDCs important in driving incidence? BJ Coburn, DJ Gerberry, & S Blower. Quantification of the role of discordant couples in driving incidence of HIV in sub-saharan Africa. Lancet Infect Dis 2011, 11: Would targeting SDCs for prevention have a significant impact? WM El-Sadr, BJ Coburn, & S Blower. Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission. AIDS 2011, 25: Are SDC interventions feasible? BJ Coburn & S Blower. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS [in press]

3 Are SDCs important in driving incidence? BJ Coburn, DJ Gerberry, & S Blower. Quantification of the role of discordant couples in driving incidence of HIV in sub-saharan Africa. Lancet Infect Dis 2011, 11:

4 Would targeting SDCs for prevention have a significant impact? (HPTN 052) Lesotho, Malawi, Rwanda, Ghana Country-level incidence (per 1000 person-years) Annual number of infections prevented Treatment coverage in discordant couples Treatment coverage in discordant couples 70% is in stable partnerships WM El-Sadr, BJ Coburn, & S Blower. Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission. AIDS 2011, 25:

5 Are SDC interventions feasible? High (> 10%) Moderate (5-10%) Low (< 5%) BJ Coburn & S Blower. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS [in press]

6 Locations of the 14 countries BJ Coburn & S Blower. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS [in press]

7 Research Questions (i) Are HIV prevalence and the level of discordancy correlated? (i) What is the number per 1,000 individuals that are HIV-positive (HIV-negative) in SDC? (i) What is the percent of HIV-positive (HIVnegative) individuals are in SDC? Demographic & Health Survey data Mathematical modeling BJ Coburn & S Blower. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS [in press]

8 (i) Are HIV prevalence and the level of discordancy correlated? y = A(e ax 1) + ε HIV Prevalence (%) HIV prevalence (y) level of discordancy (x) â = 0.13 (95% CI: 0.10, 0.17) Â = 4.37 (95% CI: 2.60, 7.57) Level of Discordancy (%) Error term (ε) BJ Coburn & S Blower. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS [in press]

9 Utility: Unknown discordancy Inverse function: HIV Prevalence (%) x = 1 a log 1+ y A Example: HIV prevalence 10% discordancy ~9% Level of Discordancy (%) BJ Coburn & S Blower. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS [in press]

10 (ii) What is the number per 1,000 individuals that are HIV-positive in SDC? Prevalence? Singles Couples Country-level Prevalence (from data) DHS Data Set

11 (ii) What is the number per 1,000 individuals that are HIV-positive in SDC? per 1000 individuals in SDCs per 1000 individuals in SDCs 3-19 per 1000 individuals in SDCs HIV-negative in SDC? BJ Coburn & S Blower. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. AIDS [in press]

12 (iii) What is the percent of HIV-positive (HIVnegative) individuals are in SDC? HIV-positive individuals (> 10%) 20-27% serodiscordant couples 40-58% concordant couples 22-33% single HIV-negative individuals (all countries) < 6% serodiscordant couples

13 Implications for Epidemic Control Interventions PrEP (ineffective SDCs) Singles TasP (effective SDCs) Feasibility (TasP) >10%, possible (challenging) <5%, unlikely

14 Thank you for listening Questions

Downloaded from:

Downloaded from: Hayes, R; Fidler, S; Cori, A; Fraser, C; Floyd, S; Ayles, H; Beyers, N; El-Sadr, W; HPTN 071 (PopART) Study Team (2015) HIV Treatment-As-Prevention Research: Taking the Right Road at the Crossroads. PLoS

More information

Supplemental Digital Content

Supplemental Digital Content Supplemental Digital Content 1 Methodology for estimating the contribution of identifiable HIV incidence among stable HIV-1 sero-discordant couples to total HIV population-level incidence We based our

More information

Can we treat our way out of the HIV epidemic?

Can we treat our way out of the HIV epidemic? Can we treat our way out of the HIV epidemic? Richard E. Chaisson, MD Center for AIDS Research Center for TB Research Johns Hopkins University Schoolboy s (and politician s) tricks for evading the question

More information

Multiple choice questions: ANSWERS

Multiple choice questions: ANSWERS Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible

More information

Immunologic and Virologic Disease Progression and Response to ART Across Geographic Regions: Outcomes from HPTN 052

Immunologic and Virologic Disease Progression and Response to ART Across Geographic Regions: Outcomes from HPTN 052 Immunologic and Virologic Disease Progression and Response to ART Across Geographic Regions: Outcomes from HPTN 052 Mina C. Hosseinipour, MD, MPH Site Investigator UNC Project, Lilongwe, Malawi UNC School

More information

Torin Schaafsma. A thesis submitted in partial fulfillment of the requirements for the degree of. Master of Science. University of Washington 2015

Torin Schaafsma. A thesis submitted in partial fulfillment of the requirements for the degree of. Master of Science. University of Washington 2015 Estimating the impact of identifying and treating HIV-infected male circumcision clients in Uganda, Zambia, and Swaziland: a mathematical modeling analysis Torin Schaafsma A thesis submitted in partial

More information

Julio Montaner MD, DSc(hon), FRCPC, FCCP, FRSC, OBC

Julio Montaner MD, DSc(hon), FRCPC, FCCP, FRSC, OBC Julio Montaner MD, DSc(hon), FRCPC, FCCP, FRSC, OBC Director, BC-Centre for Excellence in HIV/AIDS, Providence Health Care Professor of Medicine and Head, Division of AIDS, University of British Columbia

More information

State of the Art for ART for Prevention. Wafaa El-Sadr, MD, MPH ICAP-Columbia University

State of the Art for ART for Prevention. Wafaa El-Sadr, MD, MPH ICAP-Columbia University State of the Art for ART for Prevention Wafaa El-Sadr, MD, MPH ICAP-Columbia University Millions Global Scale-Up of HIV Treatment 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 End of 2002 End of 2003 End of 2004

More information

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort Frank Tanser Presentation at the South African Clinicians Society Conference

More information

HIV : Test and Treat?

HIV : Test and Treat? HIV : Test and Treat? 14 th HIV Resistance Meeting 22.9.10 Why now? Test and Treat What does it mean? Could it work-what is the evidence? What are the challenges? 1 Universal ART Access 2008 UNAIDS 33

More information

Using anti-hiv drugs for prevention

Using anti-hiv drugs for prevention Using anti-hiv drugs for prevention Highlights from AIDS 2012 (and 2 nd International Workshops on Treatment as Prevention) Tim Rogers, trogers@catie.ca Using anti-hiv Drugs for Prevention Outline Treatment

More information

A smart and doable investment

A smart and doable investment 90-90-90 A smart and doable investment As of December 2013 Adults and children living with HIV Adults and children newly infected Adult & child deaths due to AIDS 35.0 million [33.2 million 37.2 million]

More information

Combination prevention: Public health and human rights imperatives

Combination prevention: Public health and human rights imperatives Combination prevention: Public health and human rights imperatives Gottfried Hirnschall, MD MPH HIV/AIDS Department WHO, Geneva London, June 11, 2012 Outline The epidemic and response What is combination

More information

The Faithful House and Uganda s National Campaign: Go Together, Know Together THE FAITHFUL HOUSE

The Faithful House and Uganda s National Campaign: Go Together, Know Together THE FAITHFUL HOUSE The Faithful House and Uganda s National Campaign: Go Together, Know Together THE FAITHFUL HOUSE Cover photo: Faithful House participants laugh together. The Faithful House program is a three day workshop

More information

Combination HIV Prevention

Combination HIV Prevention Combination HIV Prevention Timothy Mastro, MD, FACP, DTM&H FHI 360, Durham, North Carolina, USA 7 th INTEREST Workshop, Dakar, Senegal 15 May 2013 Outline What Works for HIV Prevention? Highly Active

More information

Treatment as Prevention

Treatment as Prevention Optimizing the Impact of ART Treatment as Prevention A Made-in-BC Strategy to End the AIDS Pandemic Julio Montaner, OC, OBC, MD Professor of Medicine and Head, Division of AIDS, University of British Columbia

More information

ART FOR ART PREVENTION. Introduction of ongoing or planned trials

ART FOR ART PREVENTION. Introduction of ongoing or planned trials ART FOR ART PREVENTION Introduction of ongoing or planned trials François Dabis, MD, PhD for WHO Department of HIV/AIDS Geneva - November 3, 2009 ART FOR ART PREVENTION as of November 2009 Descriptive

More information

Renewing Momentum in the fight against HIV/AIDS

Renewing Momentum in the fight against HIV/AIDS 2011 marks 30 years since the first cases of AIDS were documented and the world has made incredible progress in its efforts to understand, prevent and treat this pandemic. Progress has been particularly

More information

Modelling HIV prevention: strengths and limitations of different modelling approaches

Modelling HIV prevention: strengths and limitations of different modelling approaches Modelling HIV prevention: strengths and limitations of different modelling approaches Leigh Johnson Centre for Infectious Disease Epidemiology and Research Background Models of HIV differ greatly in their

More information

DAY 1: MODELING ACTS versus PARTNERSHIPS

DAY 1: MODELING ACTS versus PARTNERSHIPS DAY 1: MODELING ACTS versus PARTNERSHIPS NME WORKSHOP Darcy Rao Objectives Objectives Delve deeper into how compartmental and agentbased models represent partnership dynamics How are sex partners selected?

More information

Antiretroviral therapy for prevention of HIV transmission: implications for Europe

Antiretroviral therapy for prevention of HIV transmission: implications for Europe Review articles Antiretroviral therapy for prevention of HIV transmission: implications for Europe V Cambiano (v.cambiano@ucl.ac.uk) 1, J O Connor 1, A N Phillips 1, A Rodger 1, R Lodwick 2, A Pharris

More information

Use of Pre-exposure Prophylaxis (PrEP) in pregnancy for primary prevention of HIV infection in women

Use of Pre-exposure Prophylaxis (PrEP) in pregnancy for primary prevention of HIV infection in women Use of Pre-exposure Prophylaxis (PrEP) in pregnancy for primary prevention of HIV infection in women Catherine Hankins MD PhD FRCPC CM Deputy Director, Science Amsterdam Institute for Global Health and

More information

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

More information

Strategic use of antiretroviral drugs to prevent HIV transmission

Strategic use of antiretroviral drugs to prevent HIV transmission Strategic use of antiretroviral drugs to prevent HIV transmission 22th Tunisian Congress of Infectious Diseases 2nd Congress of Federation of Arab Societies of Clinical Microbiology and Infectious Diseases

More information

Using the INDEPTH model life tables to. mortality rates for. projections. John Gordon INDEPTH AGM DSM 2008

Using the INDEPTH model life tables to. mortality rates for. projections. John Gordon INDEPTH AGM DSM 2008 Using the INDEPTH model life tables to estimate baseline e mortality rates for HIV/AIDS demographic projections John Gordon INDEPTH AGM DSM 2008 Background The approach taken is a combination of applied

More information

Kigali Province East Province North Province South Province West Province discordant couples

Kigali Province East Province North Province South Province West Province discordant couples EXECUTIVE SUMMARY This report summarizes the processes, findings, and recommendations of the Rwanda Triangulation Project, 2008. Triangulation aims to synthesize data from multiple sources to strengthen

More information

CAN MONEY REDUCE HIV RISK?? Audrey Pettifor, PhD MPH Department of Epidemiology, University of North Carolina

CAN MONEY REDUCE HIV RISK?? Audrey Pettifor, PhD MPH Department of Epidemiology, University of North Carolina CAN MONEY REDUCE HIV RISK?? Audrey Pettifor, PhD MPH Department of Epidemiology, University of North Carolina Overview Epidemiology of HIV in young people Rationale behind cash transfers Review completed

More information

Age-Sex Structure for Selected African countries in the early 2000s

Age-Sex Structure for Selected African countries in the early 2000s Age-Sex Structure for Selected African countries in the early 2000s Abstract This paper uses data from the recent United Nations population projections to examine the changing age-sex structure in selected

More information

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort

The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort Frank Tanser Presentation at 8 th International Workshop on HIV Treatment,

More information

Enrollment of high risk men in Africa

Enrollment of high risk men in Africa Enrollment of high risk men in Africa Susan Allen MD MPH Professor, Department of Pathology and Laboratory Medicine Emory University Rwanda Zambia HIV Research Group Africa Population 950 million by Region

More information

90% 90% 90% 30% 10% 5% 70% 90% 95% WHY HIV SELF-TESTING? PLHIV diagnosed PLHIV undiagnosed

90% 90% 90% 30% 10% 5% 70% 90% 95% WHY HIV SELF-TESTING? PLHIV diagnosed PLHIV undiagnosed WHY HIV SELF-TESTING? In 2014, the United Nations set bold new targets, calling on the global community to ensure that by 2020, 90% of all people living with HIV will know their HIV status, 90% of all

More information

Biomedical Prevention in HIV

Biomedical Prevention in HIV Biomedical Prevention in HIV CHART - CCAS-CDC 3 RD Joint Meeting Montego Bay, Jamaica August 21-26,2011 Presented by Tina Hylton-Kong, ERTU-CHART Some Slides from Impact of ART on HIV Transmission Wafaa

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content El-Sadr WM, Donnell D, Beauchamp G, et al. Financial incentives for linkage to care and viral suppression among HIV-positive patients: a randomized clinical trial (HPTN 065)

More information

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE

QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu QUESTIONS AND ANSWERS ABOUT PARTNERS PrEP AND VOICE 1. What is the Partners PrEP study? The Partners PrEP Study is a double-blind,

More information

HIV/AIDS and Fertility

HIV/AIDS and Fertility Becker Fellow University of Chicago Background Contribution Background: The HIV/AIDS Epidemic HIV prevalence in sub-saharan Africa increased substantially in the late 1980s and early 1990s Life expectancy

More information

Partners for Health Reformplus. Strengthening Health System Responses to HIV/AIDS

Partners for Health Reformplus. Strengthening Health System Responses to HIV/AIDS Partners for Health Reformplus Strengthening Health System Responses to HIV/AIDS Summary o Costing HIV/AIDS Treatment Services As countries begin to seriously explore introducing antiretroviral (ARV) treatment

More information

Clinical and Public Health Policy Implications of Findings that:

Clinical and Public Health Policy Implications of Findings that: Clinical and Public Health Policy Implications of Findings that: Adherence to HIV Medications and Emotional/Physiological Coping with Stress are Independently Associated with Specific Five-Year Outcome

More information

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges George Siberry, MD, MPH OGAC Senior Technical Advisor for Pediatrics March, 2016 Compared to Adults, Children (

More information

HP+/Project SOAR Oral PrEP Modeling. Webinar Series: Five Ways to Accelerate Progress Toward the Goals January 16, 2018

HP+/Project SOAR Oral PrEP Modeling. Webinar Series: Five Ways to Accelerate Progress Toward the Goals January 16, 2018 HP+/Project SOAR Oral PrEP Modeling Webinar Series: Five Ways to Accelerate Progress Toward the 95-95-95 Goals January 16, 2018 Activity Overview 2 Activity Objective Provide impact, cost, and cost-effectiveness

More information

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Rationale for the call to action, progress to date and dealing with realities Rene Ekpini, MD, MPH Senior Adviser,

More information

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012 PMTCT Update Update on PMTCT Margarett Davis, MD, MPH Chief, Maternal and Child Health Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention (CDC) African Health Profession Regulatory

More information

Levels and Predictors of Condom Use in Extramarital Sex among Women in Four sub- Saharan African Countries

Levels and Predictors of Condom Use in Extramarital Sex among Women in Four sub- Saharan African Countries Levels and Predictors of Condom Use in Extramarital Sex among Women in Four sub- Saharan African Countries Onipede Wusu, PhD Department of Sociology, Lagos State University, Lagos, Nigeria onipedewusu@yahoo.com;

More information

HIV Clinical Update- HIV prevention

HIV Clinical Update- HIV prevention HIV Clinical Update- HIV prevention 18 th Australian and New Zealand Conference on Haemophilia and Rare Bleeding Disorders, Melbourne October 13 th 2017 Edwina Wright Disclosures None in the past 12 months

More information

Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs

Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Module Time Learning Objectives To provide the participants with the basic concepts of

More information

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS

Progress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS 10 th International Workshop on HIV treatment, Pathogenesis and Prevention Research in Resource-Limited setting (INTEREST, 3-6 May, 2016) Progress in scaling up HIV prevention and treatment in sub-saharan

More information

HIV in Women. Why We Need Female- controlled Prevention. Heather Watts, MD March 21, 2017

HIV in Women. Why We Need Female- controlled Prevention. Heather Watts, MD March 21, 2017 HIV in Women Why We Need Female- controlled Prevention Heather Watts, MD March 21, 2017 Since the Start of PEPFAR, New HIV Infections Have Declined 51-76% 1.6 Reduction in rate of new HIV infections (incidence

More information

Biomedical HIV Prevention & TaP Treatment as Prevention 2013

Biomedical HIV Prevention & TaP Treatment as Prevention 2013 Biomedical HIV Prevention & TaP Treatment as Prevention 2013 Community Education Team The AIDS Institute/AIDS Alliance Be the Generation to End the AIDS Epidemic bethegeneration.nih.gov www.aids-alliance.org/education/vaccine

More information

Treatment as Prevention

Treatment as Prevention Treatment as Prevention The Key to an AIDS-Free Generation Julio Montaner MD, DSc(hon), FRCPC, FCCP, FRSC, OBC Director, BC-Centre for Excellence in HIV/AIDS, Providence Health Care Professor of Medicine

More information

Treat All : From Policy to Action - What will it take?

Treat All : From Policy to Action - What will it take? Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions

More information

HIV Prevention Strategies HIV Pre-exposure prophylaxis

HIV Prevention Strategies HIV Pre-exposure prophylaxis HIV Prevention Strategies HIV Pre-exposure prophylaxis Michael Martin, MD, MPH Director HIV Research Program Thailand MOPH U.S. CDC Collaboration The findings and conclusions in this presentation are those

More information

Ending The HIV/AIDS Epidemic in America

Ending The HIV/AIDS Epidemic in America Ending The HIV/AIDS Epidemic in America Unique Moment in History Media inquiries: Matt Matassa 703.647.1909; mmatassa@fhi.org FOR IMMEDIATE RELEASE: Thursday, 12 May 2011, 11 am EST Initiation of Antiretroviral

More information

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments There are two options for accessing the audio portion of this webinar: (1) Using your

More information

HIV Prevention. Recent Advances and Implications for the Caribbean

HIV Prevention. Recent Advances and Implications for the Caribbean HIV Prevention Recent Advances and Implications for the Caribbean Chris Behrens, MD CCAS/CHART Conference Barbados, August 2010 Cases 200 180 160 140 120 100 80 60 40 20 0 Year HIV Cases AIDS Cases HIV

More information

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030

FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Evidence informed, responsive and sustainable care FAST-TRACK: HIV Prevention, treatment and care to End the AIDS epidemic in Lesotho by 2030 Alti Zwandor UNAIDS Country Director Maseru, Lesotho 9 December

More information

Cost per HIV-infection averted (HIA) through Couples VCT in Zambia

Cost per HIV-infection averted (HIA) through Couples VCT in Zambia Cost per HIV-infection averted (HIA) through Couples VCT in Zambia M. Inambao, K. Wall, W. Kilembe, E. Karita, A. Ticachek, G. Streeb, I. Thior, J. Pulerwitz, E. Chomba, S. Allen Zambia Emory HIV research

More information

HIV: A global perspective on epidemiology, diagnosis and prevention

HIV: A global perspective on epidemiology, diagnosis and prevention HIV: A global perspective on epidemiology, diagnosis and prevention Margaret McLees, M.D., DTMH Instructor, Division of Infectious Diseases Denver Health University of Colorado November 13, 2012 Outline

More information

DREAMS LITERATURE REVIEW

DREAMS LITERATURE REVIEW DREAMS LITERATURE REVIEW Produced by: Lola Arakaki, Jessica Farley, Ann Duerr Agenda Introduction Background Project objectives Methods Results Recommendations 2 Introduction BACKGROUND Adolescent girls

More information

Inspiring HIV Prevention Innovations for Women. IPM Satellite Event Durban, 13 th June 2017 Annalene Nel

Inspiring HIV Prevention Innovations for Women. IPM Satellite Event Durban, 13 th June 2017 Annalene Nel Inspiring HIV Prevention Innovations for Women IPM Satellite Event Durban, 13 th June 2017 Annalene Nel HIV Infection: Where We Are Today 30+ years since the US CDC reported the first cases of AIDS 25.5

More information

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

On the Horizon for Consideration: Biomedical Advances in HIV Prevention On the Horizon for Consideration: Biomedical Advances in HIV Prevention Francisco Ruiz, MS Senior Manager, National Alliance of State and Territorial AIDS Directors New Jersey Governor's Advisory Council

More information

HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE

HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE THE REMAINING CHALLENGES DR YOGAN PILLAY, NDOH SA HIV CLINICIANS SOCIETY CONFERENCE, CAPE TOWN 25 NOVEMBER, 2012 GLOBAL DATA 34m people living with

More information

In southern and East Africa, the epidemic of HIV has increased

In southern and East Africa, the epidemic of HIV has increased Antiretroviral therapy for tuberculosis control in nine African countries Brian G. Williams a,1, Reuben Granich b, Kevin M. De Cock b, Philippe Glaziou b, Abhishek Sharma c, and Christopher Dye b a South

More information

Reflec%ons on the Role of Discordant Couples and the HIV Epidemic. Implementa%on Science and Male Circumcision in Rakai

Reflec%ons on the Role of Discordant Couples and the HIV Epidemic. Implementa%on Science and Male Circumcision in Rakai Reflec%ons on the Role of Discordant Couples and the HIV Epidemic Implementa%on Science and Male Circumcision in Rakai Ron Gray & Maria Wawer Johns Hopkins University Discordant couples, why are they important?

More information

Is this the end of AIDS? New advances in HIV prevention. James McIntyre Anova Health Institute and University of Cape Town School of Public Health

Is this the end of AIDS? New advances in HIV prevention. James McIntyre Anova Health Institute and University of Cape Town School of Public Health Is this the end of AIDS? New advances in HIV prevention. James McIntyre Anova Health Institute and University of Cape Town School of Public Health Thirty years of AIDS July 3, 1981 A generation in the

More information

To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.

To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling. Module 2 Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Learning Objectives To provide you with the basic concepts of HIV prevention using HIV rapid

More information

Extra-couple HIV transmission in sub-saharan Africa: a mathematical modelling study of survey data

Extra-couple HIV transmission in sub-saharan Africa: a mathematical modelling study of survey data Extra-couple HIV transmission in sub-saharan Africa: a mathematical modelling study of survey data Steve E Bellan, Kathryn J Fiorella, Dessalegn Y Melesse, Wayne M Getz, Brian G Williams, Jonathan Dushoff

More information

TasP - Individual versus Public Health Benefit versus Both.

TasP - Individual versus Public Health Benefit versus Both. Site Map l Contact Us l Calendar l Join AVAC Donate TasP - Individual versus Public Health Benefit versus Both. Kevin Fisher Policy Director, AVAC June 2012 Multiple choice answer: all of the above We

More information

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

Sex Work in Sub-Saharan Africa : Opportunities and Challenges Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or

More information

Modeling HIV and STI transmission dynamics: The importance of partnership network structure

Modeling HIV and STI transmission dynamics: The importance of partnership network structure Modeling HIV and STI transmission dynamics: The importance of partnership network structure Martina Morris University of Washington Departments of Sociology and Statistics Network Modeling Project: Steve

More information

HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes

HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes Review HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes Wim Delva 1,2 *, Jeffrey W. Eaton 3, Fei Meng 2,4, Christophe Fraser 3, Richard G. White 5, Peter Vickerman

More information

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff

Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State

More information

HIV Update For the Internist

HIV Update For the Internist HIV Update For the Internist Disclosures I declare that I have received no incentives, financial or otherwise, from pharmaceutical or biomedical companies relevant to the content of this talk. As an Infectious

More information

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv The HIV/AIDS Epidemic and Sustainable Development tgoals Etienne Karita, MD MSc MSPH Kigali, 8 Nov 018 IV/AIDS Burden Since the start t of the HIV/ V/AIDS epidemic i in the early 1980 s: 77.3 million people

More information

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS 29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A

More information

Understanding the Results of VOICE

Understanding the Results of VOICE CONTACT: Lisa Rossi +1-412- 916-3315 (mobile) or +27-(0)73-323-0087 (through 7 March) rossil@upmc.edu About VOICE Understanding the Results of VOICE VOICE Vaginal and Oral Interventions to Control the

More information

Ending the AIDS epidemic: Science, Policy and Community. Peter Godfrey-Faussett, UNESCO Merck Africa Research Summit 19/10/2015

Ending the AIDS epidemic: Science, Policy and Community. Peter Godfrey-Faussett, UNESCO Merck Africa Research Summit 19/10/2015 Ending the AIDS epidemic: Science, Policy and Community Peter Godfrey-Faussett, UNESCO Merck Africa Research Summit 19/10/2015 The cooking pot sits on three stones Science Policy Community Science 20 May

More information

Africa s slow fertility transition

Africa s slow fertility transition Africa s slow fertility transition John Bongaarts Population Council, New York Süssmilch Lecture Max Planck Institute, Rostock 3 Sep 215 Billions 4 3 Population projections for sub-saharan Africa 215 projection

More information

All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON

All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON All [HIV-exposed] infants should receive oral antiretroviral prophylaxis for the entire duration of breastfeeding - CON Amy Slogrove Stellenbosch University 10 th International HIV Pediatrics Workshop

More information

HIV/AIDS Country Publications

HIV/AIDS Country Publications 1 de 5 01/07/2008 18:18 Publications POLICY at Barcelona The following are abstracts of papers and posters accepted for presentation at the International AIDS Conference 2002: Cost savings and affordability

More information

Biomedical Prevention Update Thomas C. Quinn, M.D.

Biomedical Prevention Update Thomas C. Quinn, M.D. Biomedical Prevention Update Thomas C. Quinn, M.D. Associate Director of International Research National Institute of Allergy and Infectious Diseases Director, Johns Hopkins Center for Global Health Global

More information

HPTN Community Working Group 2017 IAS Debrief

HPTN Community Working Group 2017 IAS Debrief HPTN Community Working Group 2017 IAS Debrief Drs. Mike Cohen and Wafaa El-Sadr provided a forum for the HPTN CWG to hear more about the HPTN activity at the International AIDS Society meeting in Paris.

More information

Novel HIV Prevention Methods for Women

Novel HIV Prevention Methods for Women Novel HIV Prevention Methods for Women State of the art injectables, rings, and antibody-mediated prevention Nyaradzo M Mgodi (MBChB, MMed) Principal Investigator University of Zimbabwe- College of Health

More information

Improving Efficiency in Health Washington, D.C. 3 February 2016

Improving Efficiency in Health Washington, D.C. 3 February 2016 HIV Resource Allocation using the Goals Model John Stover Adebiyi Adesina, Lori Bollinger, Rudolph Chandler, Eline Korenromp, Guy Mahiane, Carel Pretorius, Rachel Sanders, Peter Stegman, Michel Tcheunche,

More information

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa HPTN 075 Protocol Chair: Theo Sandfort New York State Psychiatric Institute and Columbia University

More information

HIV In South Africa: Turning the Tide of the Epidemic

HIV In South Africa: Turning the Tide of the Epidemic HIV In South Africa: Turning the Tide of the Epidemic Jean B. Nachega, MD, PhD Associate Professor Department of Epidemiology Pittsburgh University, Graduate School of Public Health E-mail: JBN16@PITT.EDU

More information

Use of a risk scoring tool to identify higherrisk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention

Use of a risk scoring tool to identify higherrisk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention Irungu et al. BMC Infectious Diseases (2016) 16:571 DOI 10.1186/s12879-016-1899-y RESEARCH ARTICLE Open Access Use of a risk scoring tool to identify higherrisk HIV-1 serodiscordant couples for an antiretroviral-based

More information

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world? Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world? Lut Van Damme 11 Oct 2012 1 Disclaimer Gilead donated the study product for the FEM-PrEP trial I participated

More information

Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK

Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK Dr Valerie Delpech Health Protection Agency, London (Public Health England) Outline! Brief overview Science,

More information

Financial Incentives, Linkage to Care and Viral Suppression HPTN 065 (TLC-Plus) Study. Wafaa El-Sadr ICAP at Columbia University New York, NY

Financial Incentives, Linkage to Care and Viral Suppression HPTN 065 (TLC-Plus) Study. Wafaa El-Sadr ICAP at Columbia University New York, NY Financial Incentives, Linkage to Care and Viral Suppression HPTN 065 (TLC-Plus) Study Wafaa El-Sadr ICAP at Columbia University New York, NY Outline of Presentation Background and study rationale Methods

More information

Christina Psaros, Ph.D. (presenting author) Massachusetts General Hospital / Harvard Medical School, Boston, MA

Christina Psaros, Ph.D. (presenting author) Massachusetts General Hospital / Harvard Medical School, Boston, MA Evaluation and process outcomes from an adherence intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda Christina Psaros, Ph.D. (presenting author)

More information

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles Marelize Gorgens mgorgens@worldbank.org The World Bank s Global HIV/AIDS Program

More information

E ffective prevention strategies for controlling the HIV pandemic are urgently needed. One potential strategy,

E ffective prevention strategies for controlling the HIV pandemic are urgently needed. One potential strategy, SUBJECT AREAS: COMPUTATIONAL BIOLOGY DISEASES BIOLOGICAL MODELS HIV Received 12 September 2011 Accepted 23 November 2011 Published 7 December 2011 Correspondence and requests for materials should be addressed

More information

Spectrum. Quick Start Tutorial

Spectrum. Quick Start Tutorial Spectrum Quick Start Tutorial March 2005 Table of Contents Introduction... 2 What you will learn... 4 Basic Steps in Using Spectrum... 4 Step 1. Installing Spectrum... 4 Step 2. Changing the language in

More information

Antiretrovirals for HIV prevention:

Antiretrovirals for HIV prevention: Antiretrovirals for HIV prevention: Topical PrEP, Systemic PrEP and Treatment for Prevention Presentation at 6th International workshop on HIV treatment, pathogenesis and prevention research in resource-limited

More information

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London When PrEP fails Laura Waters MD FRCP Mortimer Market Centre London www.aidsunited.org PrEP works If people at risk take it If it s taken in the right way If it s available Commissioned/licensed Affordable

More information

People left behind: People living with HIV

People left behind: People living with HIV GAP Report 2014 People left behind: People living with HIV Link with the pdf, People living with HIV I am a person living with HIV. I face these issues. HIV burden There are 35 million people living with

More information

HPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission

HPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission HPTN 071 (PopART) Population Effects of Antiretroviral Therapy to Reduce HIV Transmission TWEET LIVE #HPTN071 DIAL IN NUMBER FOR AUDIO: 1-866-740-1260 BROADCAST AUDIO CODE: 4011527 PLEASE USE THE CHAT

More information

UNAIDS 2013 AIDS by the numbers

UNAIDS 2013 AIDS by the numbers UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since

More information

Understanding the Impact of an HIV Intervention Package for Adolescents

Understanding the Impact of an HIV Intervention Package for Adolescents Understanding the Impact of an HIV Intervention Package for Adolescents Faikah Bruce Supervisors: Dr. Leigh Johnson (UCT - CIDER) and Prof. Alex Welte (SU - SACEMA) 1 Contents Introduction Literature Review

More information

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology

More information

Male involvement in HIV Prevention Trials

Male involvement in HIV Prevention Trials Male involvement in HIV Prevention Trials Examples from HPTN071 Helen Ayles London School of Hygiene and Tropical Medicine Zambart, Lusaka, Zambia Introduction Equity is the absence of avoidable or remediable

More information